Activation of the transcriptional factor NF-κB, a downstream target for TLR-MyD88 signaling, is crucial for the inflammatory response in immune cells and is a key in the development of NAFLD [10, 11]. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.